Mufaasa Pharmaceuticals Private Limited

Mufaasa Pharmaceuticals Private Limited - pharma in Ahmedabad, Gujarat, India. Directors, charges & compliance details.
CIN U85100GJ2023PTC138427 Incorporated 13 January 2023 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹6.28 Lakh
Latest filing
Net profit · FY 2025
₹30,630
Net margin 4.9%
EBITDA · FY 2025
₹30,630
EBITDA margin 4.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
3 yrs
Est. 2023
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Mufaasa Pharmaceuticals Private Limited

Data last updated:

Mufaasa Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 January 2023.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U85100GJ2023PTC138427. Its GSTIN is 24AAHCE4273F1ZS (Gujarat).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sarojben Ramprakash Kothari and Shreeya Ramprakash Kothari.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 3 Old L R Apartments Nr Shahibag Rly Crossing Shahibag, Ahmedabad, Gujarat, India – 380004.

As per the financials filed for FY 2025, the company reported a revenue of ₹6.28 Lakh. For the same year it recorded a net profit of ₹30,630 (net margin 4.9%) and EBITDA of ₹30,630 (EBITDA margin 4.9%).

Mufaasa Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0283679). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U85100GJ2023PTC138427
Registration Number 138427
Incorporation Date 13 January 2023
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0283679

Recognitions & Rankings of Mufaasa Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-GJ-01-0283679

Contact details

Mufaasa Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat.

  • Registered Address
    Flat No. 3 Old L R Apartments Nr Shahibag Rly Crossing Shahibag, Ahmedabad, Gujarat, India – 380004
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Mufaasa Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Mufaasa Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Mufaasa Pharmaceuticals Private Limited, buy the company report.

Financials of Mufaasa Pharmaceuticals Private Limited

FY 2025 filings available

Mufaasa Pharmaceuticals Private Limited reported revenue of ₹6.28 Lakh for FY 2025.

Revenue · FY 2025
₹6.28 Lakh
Net profit · FY 2025
₹30,630 margin 4.9%
EBITDA · FY 2025
₹30,630 margin 4.9%

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹30,630
Profit Before Tax
Tax Expense
Net Profit (PAT)₹30,630
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin4.9%
Net Profit Margin4.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Mufaasa Pharmaceuticals Private Limited, buy the company report.

Board of directors of Mufaasa Pharmaceuticals Private Limited

Mufaasa Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sarojben Ramprakash KothariDirector13 Jan 20233 Years 9 MonthsCurrent
Shreeya Ramprakash KothariDirector13 Jan 20233 Years 9 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Mufaasa Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Mufaasa Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAHCE4273F1ZSGujaratActive02 May 2023

To see the full GST registrations and return filing status of Mufaasa Pharmaceuticals Private Limited, buy the company report.

Recent activity

Mufaasa Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Sarojben Ramprakash Kothari was appointed as Director on 13 Jan 2023.

AGM
Mufaasa Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Mufaasa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Appointed
Sarojben Ramprakash Kothari was appointed as Director.
Appointed
Shreeya Ramprakash Kothari was appointed as Director.
Incorporation
13 Jan 2023
Mufaasa Pharmaceuticals Private Limited was registered on 13 Jan 2023 with Roc Ahmedabad & aged 3 years 9 months as per MCA records.

Frequently asked questions

Mufaasa Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 January 2023 (3+ years old) and is registered under CIN U85100GJ2023PTC138427.

Mufaasa Pharmaceuticals has 2 current directors:

The latest financial statements of Mufaasa Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The GSTIN of Mufaasa Pharmaceuticals is 24AAHCE4273F1ZS, registered in Gujarat.

The CIN (Corporate Identification Number) of Mufaasa Pharmaceuticals is U85100GJ2023PTC138427. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Mufaasa Pharmaceuticals was incorporated on 13 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Sarojben Ramprakash Kothari was appointed as Director on 13 Jan 2023. Shreeya Ramprakash Kothari was appointed as Director on 13 Jan 2023.

Yes, Mufaasa Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0283679).

The registered office of Mufaasa Pharmaceuticals is at Flat No. 3 Old L R Apartments Nr Shahibag Rly Crossing Shahibag, Ahmedabad, Gujarat, India – 380004.

Mufaasa Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.